A A Chaves1, W J Keller, S O'Sullivan
1Safety Assessment, Merck Research Laboratories, P.O. Box 4, West Point, PA 19486, United States.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study demonstrates that a primate telemetry model reliably predicts QT interval prolongation, a key indicator of drug safety. This preclinical model effectively identifies potential pro-arrhythmia risks in novel human pharmaceuticals.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: